Literature DB >> 27807707

A Comparative Study of Video-Assisted Thoracic Surgery with Thoracotomy for Middle Lobe Syndrome.

Jian Li1,2, Chengwu Liu1,2, Yongsheng Zhao1,2, Chuan Li1,2, Lunxu Liu3,4.   

Abstract

OBJECTIVES: The aim of this study is to evaluate the feasibility and safety of video-assisted thoracic surgery (VATS) for the treatment of middle lobe syndrome (MLS) through comparison with thoracotomy during the same period.
METHODS: We retrospectively reviewed all consecutive patients with MLS who underwent lobectomy or lingular segmentectomy between December 2005 and November 2015 in a single institute. Thirty patients were enrolled and divided into two groups: VATS group (n = 19) and thoracotomy group (n = 11). Data regarding the patients' demographics, medical history were collected and statistically compared.
RESULTS: All patients received successful middle lobe resection or lingular segmentectomy. In terms of operation time, blood transfusion, chest drainage amount, duration of chest drainage and postoperative complications, no significant differences were found between the two groups (p > 0.05). The mean intraoperative blood loss of VATS group was less than thoracotomy group (79.0 ± 63.9 vs. 165 ± 94.9 ml, p = 0.04). In VATS group, the mean length of postoperative hospital stay was 6.0 ± 2.4 days, shorter than that in group thoracotomy (9.0 ± 3.5 days, p = 0.01).
CONCLUSIONS: VATS was a feasible and safe method for the surgical treatment of MLS in selected patients when no severe calcified lymph nodes surrounding hilus pulmonis was observed by preoperative chest CT scan.

Entities:  

Mesh:

Year:  2017        PMID: 27807707      PMCID: PMC5313576          DOI: 10.1007/s00268-016-3777-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


Introduction

The name of “middle lobe syndrome” (MLS) was suggested by Graham et al. [1]. Extraluminal or intraluminal bronchial obstruction, recurrent atelectasis of the right middle lobe or left lingular segment was defined as MLS [2]. Most patients with MLS would recover by applying antibiotics and bronchodilators, especially for non-obstructive type. Surgical intervention would be necessary for approximately one-third patients with MLS if conservative therapy fails, or complete bronchial obstruction [3-6]. Lobectomy or lingular segmentectomy was an effective surgical treatment of MLS. In 1948, Graham and Burford reported 12 patients with MLS underwent middle lobe lobectomy and detailed the intraoperative findings. After that, Fretheim and other authors sporadically reported surgical treatment for MLS (see Table 1). Among these studies, the majority of surgical procedures were performed via thoracotomy [7-10].
Table 1

Surgical treatment and postoperative outcomes of patients with MLS

AuthorsNumber of patients and (operation)Surgical procedureOutcome
Graham et al. [1]12 (12)Middle lobe lobectomy for all patientsAll were free of symptoms
Fretheim [7]19 (9)Middle lobe lobectomy for eight patientsExpectoration persisted in one patient after operation
Albo and Grimes [8]99 (38)Middle lobe lobectomy or right pneumonectomy for 38 patientsCompletely symptom-free after right middle lobectomy
Saha et al. [4]98 (31)Middle lobe lobectomy for 29 patientsWedge resection for two patientsRecurrent symptoms presented in one patientPleural effusion developed in three people, wound infection in one and atelectasis in oneOne patient died of pulmonary embolus postoperatively
Einarsson et al. [9]18 (18)Middle lobe lobectomy for all patientsOne patient was reoperated for bleeding and air leakage. Thirteen patients were cured; five other patients were improved
Seitz et al. [13]3 (3)Thoracoscopic middle lobe resection for three patientsOne patient underwent secondary procedures
Gudbjartsson and Gudmundsson [17]20 (20)Middle lobe resection for all patientsOne patient diedOne patient underwent secondary procedures because of massive drainage amount
Pejhan et al. [6]40 (40)Middle lobe lobectomy for 37 patientsBronchotomy and tumor local resection for one patientLower and middle bilobectomy for one patientUpper + middle sleeve lobectomy for one patientAll were cured

Patients except in Seitz’ study underwent thoracotomy surgery

Surgical treatment and postoperative outcomes of patients with MLS Patients except in Seitz’ study underwent thoracotomy surgery Over the past decade, with the continuous development of VATS technique, VATS has been applicable for most thoracic pathologies [11]. However, only few authors [12-14] reported VATS for the treatment of MLS. In this paper, we’d like to report one of the largest case series of MLS treated via VATS compared with traditional thoracotomy.

Materials and methods

This study included consecutive patients with MLS who were treated in the Department of Thoracic surgery of West China Hospital, Sichuan University between December 2005 and November 2015. According to surgical types, these patients were divided into VATS group (group V) and thoracotomy group (group T). Clinical data of each patient were collected and reviewed. The study protocol was approved by the institutional review board of West China Hospital. All patients received preoperative chest computed tomography (CT) scan and fiberoptic bronchoscopy. All patients were placed in the lateral decubitus position under general anesthesia with double-lumen endotracheal tube and underwent middle lobe resection or lingular segmentectomy. With respect to surgical treatment, we have no special technique than others. Classic three-portal technique was used during VATS procedures. The observation port (1 cm), utility port (3 cm) and assistant incision (1.5 cm) were placed in the 7th intercostal space at the mid-axillary line, the 3rd intercostal space at the anterior axillary line and the 9th intercostal space between the posterior axillary line and subscapular line, respectively. Both of the VATS right middle lobectomy and left lingular segmentectomy were performed following the concept of single direction as we described before [15]. Thoracotomy was performed through a classic posterolateral incision (20–30 cm) made in the 4th intercostal space. Tissues were sent to frozen section examination routinely. One chest tube would be placed at the end of each operation. All procedures were performed by thoracic surgeons who have the similar experience. Chest tube was removed when the daily drainage was <200 mL and when no air leak was identified. Patients were discharged from the hospital when there was no main complication. Data of each patient were collected from the medical records. Including gender, age, surgical approach, duration of operation, intraoperative blood loss, blood transfusion, chest drainage amount, duration of chest drainage, postoperative complications and the length of postoperative hospital stay. Statistical Product and Service Solutions (SPSS) software versions 17.0 (SPSS, Inc, Chicago, IL, USA) was used to analyze data. The Chi-square test was used to analyze categorical variables, and Mann–Whitney Wilcoxon test was used to analyze continuous variables. p value <0.05 was considered statistically significant.

Results

A total of 30 patients with MLS were enrolled, including 21 females and 9 males. The baseline demographic characteristics of the two groups are shown in Table 2. The mean age was 44.7 years (range 22–64 years). Among the 30 patients, 29 (96.7%) presented signs and symptoms prior to operation: cough with sputum production (group V ten cases; group T seven cases), cough with hemoptysis (group V five cases; group T three cases), chest pain (group V two cases; group T one cases) and dyspnea (group V one cases; group T 0 case). The other one patient was completely asymptomatic. Non-obstructive type accounts for 73.3% (group V 15 cases; group T 7 cases), the remaining 26.7% were obstructive type (group V four cases; group T four cases). The lesions were located in right middle lobes (group V 17 cases; group T 11 cases) or lingulars (group V two cases; group T 0 case). All patients received lobectomy or segmentectomy, 19 patients (63.3%) underwent VATS and 11 patients (36.7%) underwent thoracotomy.
Table 2

Demographic and baseline characteristics of all patients

VariablesGroup V (n = 19)Group T (n = 11) p value
Gender0.119
 Male45
 Female156
Age (years)42.5 ± 11.340.9 ± 17.50.764
Main symptoms
 Cough + sputum production107
 Cough + Hemoptysis53
 Chest pain21
 Dyspnea10
 Others10
Category0.433
 Obstruction44
 Non-obstruction157
Location of lesions0.617
 Right middle lobe1711
 Lingular20

Group V VATS group, group T thoracotomy group

Demographic and baseline characteristics of all patients Group V VATS group, group T thoracotomy group Two cases in group V were converted to open procedure. The incidence was 10.5%. The reasons were dense adhesions and enlarged calcified lymph nodes located in hilus pulmonis, respectively. During the operation for the second case, the middle lobe pulmonary artery was injured when dissecting the middle lobe bronchus, with blood loss of approximately 700 mL. Anatomical lobectomy was performed for 24 patients (group V 15 cases; group T 9 cases). Anatomical lingular segmentectomy was performed for two patients (group V two cases; group T 0 case). Non-anatomical lobectomy was performed for four patients (group V two cases; group T two cases). No significant differences were found between the two groups in the duration of operation, blood transfusion, chest drainage amount, duration of chest drainage and postoperative complications (p = 0.326, 0.716, 0.076, 0.346, 0.454, respectively, see Table 3). The mean intraoperative blood loss of group V was 79.0 ± 63.9 mL, less than that in group T (165.0 ± 94.9 mL, p = 0.04). The mean postoperative hospital stay length of group V was 6.0 days (range 3–15 days), shorter than in group T (9.0 days, range 4–17 days, p = 0.01); the differences were statistically significant. Only one patient of group T received blood transfusion. The most common pathology of MLS in the study was inflammation (n = 21), followed by bronchiectasis (n = 3), granulomatous (n = 1) and tuberculosis (n = 1). One patient received anti-tuberculosis treatment after confirmed tuberculosis by pathology. There was no intraoperative and postoperative mortality. Long-term postoperative follow-up was not analyzed.
Table 3

Perioperative clinical data of all patients

VariablesGroup V (n = 19)Group T (n = 11) p value
Surgical method
Anotomical lobectomy159
Anotomical segmentectomy20
Unanotomical lobectomy22
Duration of operation (min)122.3 ± 33.4150.0 ± 67.30.326
Intraoperative blood loss (ml)79.0 ± 63.9165 ± 94.90.04
Blood transfusion0/191/110.716
Chest drainage amount (ml)307.5 ± 231.0510.4 ± 408.30.076
Duration of chest drainage (days)2.9 ± 1.33.6 ± 1.80.346
Histology
 Infection129
 Bronchiectasis21
 Granulomatous10
 Tuberculosis10
 Others31
Complications020.454
 Pulmonary atelectasis01
 Air leakage01
Postoperative hospital stay (days)6.0 ± 2.49.0 ± 3.50.01
Perioperative clinical data of all patients

Discussion

MLS is an uncommon clinical entity. Originally, Graham and his colleagues [1] defined this syndrome as atelectasis of middle lobe caused by enlarged lymph nodes compressing the middle lobe bronchus. During the past 60 years, the definition of MLS has been changed. Bronchial obstruction, recurrent atelectasis no matter located in the right middle lobe or lingular segment was defined as MLS [2]. However, MLS was predominantly located in right middle lobe. Except that the middle lobe bronchus has a narrow diameter and an angular takeoff from intermediate bronchus, there are two other factors: Firstly, the right middle lobe is relatively isolated compared with left lingular segment. Therefore, more space adjacent to bronchus was left for development and enlargement of neoplasm or lymph nodes. Secondly, as other authors reported [16], right middle lobe lacks collateral ventilation, and it was the other factor that right middle lobe was vulnerably to suffer MLS. Although almost all patients with MLS presented syndromes preoperatively, the diagnosis of MLS is still hard only with medical history. Chest CT scan and fiberoptic bronchoscopy were necessary for diagnosis of MLS [4, 17]. The image of chest CT can show the location of lesions, surrounding the bronchus. Via fiberoptic bronchoscopy, intraluminal bronchus can be observed and the pathological diagnosis of MLS would be made. These two methods were useful for classification of MLS and preoperative evaluation. In this study, all patients received chest CT scan and fiberoptic bronchoscopy examination; no one was misdiagnosed. According to the situation that the involved bronchus was completely obstructed or not, MLS can be classified into obstructive and non-obstructive types. Endobronchial tumour or tuberculosis, foreign bodies often cause the obstructive type [18, 19], while benign inflammation is the main cause of non-obstructive type. In this study, we found that operation for obstruction type was more difficult than that for non-obstruction type. When the lesion was located near the orifice of the bronchus, sleeve lobectomy was necessitated to make sure of negative stump especially when there was a neoplasm. For cases with outside compression caused by extraluminal tumor or lymph nodes, there might be no space between the lesion and the bronchus and dissection would be rather difficult. The risk of conversion to thoracotomy was 2–23% in VATS lobectomies, and when the involved bronchus was surrounded by calcified lymph nodes, it would rise to 37% [20, 21]. In some cases, anatomical dissection of the vessels and bronchus could not be achieved because of dense adhesions between them. Sometimes clamping the pulmonary trunk would be helpful for the following safe dissection. However, for some cases, even if we used sharp dissection or converted to thoracotomy, dissection of the vessels and bronchus was still impossible. Then, we might transect the bronchus and pulmonary vessels together using endostapler. After the transection, a 3–0 prolene suture was used to reinforce the stump to prevent bronchopleural fistula and bleeding. In this study, there was no postoperative bleeding or bronchopleural fistula in the four patients who underwent non-anatomical lobectomy. Several limitations of our analysis were realized as follows: (1) Our study is a retrospective review; it cannot reach random assignment to treatment. (2) Although all procedures were performed by surgeons with similar experience, differences would present inevitably. And this study lacked unified criteria to select patients for VATS or thoracotomy. (3) This study only analyzed short-term patient data; hence, the long-term outcomes of VATS for MLS cannot be assessed. Considering the different surgical skills and experience of the surgeons, as well as the small patients cohort, the results did not indicate that all patients with MLS would benefit from VATS. However, considering the unusual entity of MLS, this study at least provided one of the largest cohort of patients undergoing VATS procedures. More experience of VATS in the surgical treatment of MLS is expected. We suggest that VATS resection could be performed for selected patients when no severe calcified lymph nodes surrounding hilus pulmonis are observed by preoperative chest CT scan.

Conclusions

In summary, our study indicated that VATS was a feasible and safe method for the surgical treatment of MLS in selected patients by experienced hands.
  21 in total

1.  Middle lobe syndrome.

Authors:  E A GRAHAM; T H BURFORD; J H MAYER
Journal:  Postgrad Med       Date:  1948-07       Impact factor: 3.840

2.  The so-called middle lobe syndrome.

Authors:  B FRETHEIM
Journal:  Thorax       Date:  1952-06       Impact factor: 9.139

3.  Middle lobe syndrome: a nationwide study on clinicopathological features and surgical treatment.

Authors:  Jon Thorkell Einarsson; Jonas Geir Einarsson; Helgi Isaksson; Tomas Gudbjartsson; Gunnar Gudmundsson
Journal:  Clin Respir J       Date:  2009-04       Impact factor: 2.570

4.  Video-assisted thoracic surgery lobectomy: experience with 1,100 cases.

Authors:  Robert J McKenna; Ward Houck; Clark Beeman Fuller
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

5.  Right middle lobe atelectasis associated with endobronchial silicotic lesions.

Authors:  H P Chien; T P Lin; H L Chen; T W Huang
Journal:  Arch Pathol Lab Med       Date:  2000-11       Impact factor: 5.534

6.  Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease.

Authors:  Jessica A Yu; Marvin Pomerantz; Amy Bishop; Michael J Weyant; John D Mitchell
Journal:  Eur J Cardiothorac Surg       Date:  2011-02-15       Impact factor: 4.191

7.  Experience with thoracoscopic lobectomy in infants and children.

Authors:  Steven S Rothenberg
Journal:  J Pediatr Surg       Date:  2003-01       Impact factor: 2.545

8.  Middle lobe syndrome: diagnosis and management.

Authors:  S P Saha; P Mayo; G A Long; R B McElvein
Journal:  Ann Thorac Surg       Date:  1982-01       Impact factor: 4.330

9.  Peripheral middle lobe syndrome.

Authors:  S A Rosenbloom; C E Ravin; C E Putman; W C Sealy; P Vock; T J Clark; J D Godwin; J T Chen; C Baber
Journal:  Radiology       Date:  1983-10       Impact factor: 11.105

10.  A comparative analysis of Pancoast tumour resection performed via video-assisted thoracic surgery versus standard open approaches.

Authors:  Francesco Paolo Caronia; Alfonso Fiorelli; Enrico Ruffini; Maurizio Nicolosi; Mario Santini; Attilio Ignazio Lo Monte
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.